The global Clinical Trial Manufacturing Service market projected to hit US$ 1140 million in 2025 to US$ 1490 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

Global Clinical Trial Manufacturing Service Market Trends and Analysis 2025-31

The global Clinical Trial Manufacturing Service market size is predicted to grow from US$ 1140 million in 2025 to US$ 1490 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031. Clinical trial manufacturing service is a service that provides customized production for drugs, medical devices and biological products in the clinical trial stage. This service usually includes the entire manufacturing process from raw material procurement, production process design, quality control to packaging and transportation. Clinical trial manufacturing service is designed to meet the special needs of clinical trials for products, such as small batches, multiple batches, and rapid response. Through a professional production team and advanced production equipment, clinical trial manufacturing service can ensure the safety and effectiveness of products while complying with relevant laws and regulations and regulatory requirements. In addition, this service can also provide flexible production solutions and make timely adjustments and optimizations according to the progress and needs of clinical trials. Clinical trial manufacturing service is of great significance to promoting the development of new drugs and improving the quality of clinical trials of medical devices and biological products, and provides strong support for the launch of new drugs and medical innovation. United States market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Clinical Trial Manufacturing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Clinical Trial Manufacturing Service players cover SGS, Intertek, Pharmsky, SK pharmteco, Quotient Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Clinical Trial Manufacturing Service Industry Forecast looks at past sales and reviews total world Clinical Trial Manufacturing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial Manufacturing Service sales for 2025 through 2031. With Clinical Trial Manufacturing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Manufacturing Service industry. This Insight Report provides a comprehensive analysis of the global Clinical Trial Manufacturing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Manufacturing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Clinical Trial Manufacturing Service market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Manufacturing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Manufacturing Service. This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Manufacturing Service market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Phase I Clinical Trial Manufacturing Service &nbsp;&nbsp;&nbsp; Phase II Clinical Trial Manufacturing Service &nbsp;&nbsp;&nbsp; Phase III Clinical Trial Manufacturing Service Segmentation by Application: &nbsp;&nbsp;&nbsp; Oral Medications &nbsp;&nbsp;&nbsp; Inhaled Medications &nbsp;&nbsp;&nbsp; Parenteral Medications &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; SGS &nbsp;&nbsp;&nbsp; Intertek &nbsp;&nbsp;&nbsp; Pharmsky &nbsp;&nbsp;&nbsp; SK pharmteco &nbsp;&nbsp;&nbsp; Quotient Sciences &nbsp;&nbsp;&nbsp; UPM Pharmaceuticals &nbsp;&nbsp;&nbsp; Sharp Services &nbsp;&nbsp;&nbsp; PCI &nbsp;&nbsp;&nbsp; NUVISAN &nbsp;&nbsp;&nbsp; Vetter-Pharma &nbsp;&nbsp;&nbsp; Lonza &nbsp;&nbsp;&nbsp; MAC Research &nbsp;&nbsp;&nbsp; Cambrex &nbsp;&nbsp;&nbsp; Nanopharm &nbsp;&nbsp;&nbsp; Patheon

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Clinical Trial Manufacturing Service Market Size (2020-2031) &nbsp;2.1.2 Clinical Trial Manufacturing Service Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Clinical Trial Manufacturing Service by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Clinical Trial Manufacturing Service Segment by Type &nbsp;2.2.1 Phase I Clinical Trial Manufacturing Service &nbsp;2.2.2 Phase II Clinical Trial Manufacturing Service &nbsp;2.2.3 Phase III Clinical Trial Manufacturing Service &nbsp;2.3 Clinical Trial Manufacturing Service Market Size by Type &nbsp;2.3.1 Clinical Trial Manufacturing Service Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Clinical Trial Manufacturing Service Market Size Market Share by Type (2020-2025) &nbsp;2.4 Clinical Trial Manufacturing Service Segment by Application &nbsp;2.4.1 Oral Medications &nbsp;2.4.2 Inhaled Medications &nbsp;2.4.3 Parenteral Medications &nbsp;2.4.4 Others &nbsp;2.5 Clinical Trial Manufacturing Service Market Size by Application &nbsp;2.5.1 Clinical Trial Manufacturing Service Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Clinical Trial Manufacturing Service Market Size Market Share by Application (2020-2025) 3 Clinical Trial Manufacturing Service Market Size by Player &nbsp;3.1 Clinical Trial Manufacturing Service Market Size Market Share by Player &nbsp;3.1.1 Global Clinical Trial Manufacturing Service Revenue by Player (2020-2025) &nbsp;3.1.2 Global Clinical Trial Manufacturing Service Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Clinical Trial Manufacturing Service Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Clinical Trial Manufacturing Service by Region &nbsp;4.1 Clinical Trial Manufacturing Service Market Size by Region (2020-2025) &nbsp;4.2 Global Clinical Trial Manufacturing Service Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Clinical Trial Manufacturing Service Market Size Growth (2020-2025) &nbsp;4.4 APAC Clinical Trial Manufacturing Service Market Size Growth (2020-2025) &nbsp;4.5 Europe Clinical Trial Manufacturing Service Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Clinical Trial Manufacturing Service Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Clinical Trial Manufacturing Service Market Size by Country (2020-2025) &nbsp;5.2 Americas Clinical Trial Manufacturing Service Market Size by Type (2020-2025) &nbsp;5.3 Americas Clinical Trial Manufacturing Service Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Clinical Trial Manufacturing Service Market Size by Region (2020-2025) &nbsp;6.2 APAC Clinical Trial Manufacturing Service Market Size by Type (2020-2025) &nbsp;6.3 APAC Clinical Trial Manufacturing Service Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Clinical Trial Manufacturing Service Market Size by Country (2020-2025) &nbsp;7.2 Europe Clinical Trial Manufacturing Service Market Size by Type (2020-2025) &nbsp;7.3 Europe Clinical Trial Manufacturing Service Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Clinical Trial Manufacturing Service by Region (2020-2025) &nbsp;8.2 Middle East & Africa Clinical Trial Manufacturing Service Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Clinical Trial Manufacturing Service Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Clinical Trial Manufacturing Service Market Forecast &nbsp;10.1 Global Clinical Trial Manufacturing Service Forecast by Region (2026-2031) &nbsp;10.1.1 Global Clinical Trial Manufacturing Service Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Clinical Trial Manufacturing Service Forecast &nbsp;10.1.3 APAC Clinical Trial Manufacturing Service Forecast &nbsp;10.1.4 Europe Clinical Trial Manufacturing Service Forecast &nbsp;10.1.5 Middle East & Africa Clinical Trial Manufacturing Service Forecast &nbsp;10.2 Americas Clinical Trial Manufacturing Service Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Clinical Trial Manufacturing Service Forecast &nbsp;10.2.2 Canada Market Clinical Trial Manufacturing Service Forecast &nbsp;10.2.3 Mexico Market Clinical Trial Manufacturing Service Forecast &nbsp;10.2.4 Brazil Market Clinical Trial Manufacturing Service Forecast &nbsp;10.3 APAC Clinical Trial Manufacturing Service Forecast by Region (2026-2031) &nbsp;10.3.1 China Clinical Trial Manufacturing Service Market Forecast &nbsp;10.3.2 Japan Market Clinical Trial Manufacturing Service Forecast &nbsp;10.3.3 Korea Market Clinical Trial Manufacturing Service Forecast &nbsp;10.3.4 Southeast Asia Market Clinical Trial Manufacturing Service Forecast &nbsp;10.3.5 India Market Clinical Trial Manufacturing Service Forecast &nbsp;10.3.6 Australia Market Clinical Trial Manufacturing Service Forecast &nbsp;10.4 Europe Clinical Trial Manufacturing Service Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Clinical Trial Manufacturing Service Forecast &nbsp;10.4.2 France Market Clinical Trial Manufacturing Service Forecast &nbsp;10.4.3 UK Market Clinical Trial Manufacturing Service Forecast &nbsp;10.4.4 Italy Market Clinical Trial Manufacturing Service Forecast &nbsp;10.4.5 Russia Market Clinical Trial Manufacturing Service Forecast &nbsp;10.5 Middle East & Africa Clinical Trial Manufacturing Service Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Clinical Trial Manufacturing Service Forecast &nbsp;10.5.2 South Africa Market Clinical Trial Manufacturing Service Forecast &nbsp;10.5.3 Israel Market Clinical Trial Manufacturing Service Forecast &nbsp;10.5.4 Turkey Market Clinical Trial Manufacturing Service Forecast &nbsp;10.6 Global Clinical Trial Manufacturing Service Forecast by Type (2026-2031) &nbsp;10.7 Global Clinical Trial Manufacturing Service Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Clinical Trial Manufacturing Service Forecast 11 Key Players Analysis &nbsp;11.1 SGS &nbsp;11.1.1 SGS Company Information &nbsp;11.1.2 SGS Clinical Trial Manufacturing Service Product Offered &nbsp;11.1.3 SGS Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 SGS Main Business Overview &nbsp;11.1.5 SGS Latest Developments &nbsp;11.2 Intertek &nbsp;11.2.1 Intertek Company Information &nbsp;11.2.2 Intertek Clinical Trial Manufacturing Service Product Offered &nbsp;11.2.3 Intertek Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Intertek Main Business Overview &nbsp;11.2.5 Intertek Latest Developments &nbsp;11.3 Pharmsky &nbsp;11.3.1 Pharmsky Company Information &nbsp;11.3.2 Pharmsky Clinical Trial Manufacturing Service Product Offered &nbsp;11.3.3 Pharmsky Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Pharmsky Main Business Overview &nbsp;11.3.5 Pharmsky Latest Developments &nbsp;11.4 SK pharmteco &nbsp;11.4.1 SK pharmteco Company Information &nbsp;11.4.2 SK pharmteco Clinical Trial Manufacturing Service Product Offered &nbsp;11.4.3 SK pharmteco Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 SK pharmteco Main Business Overview &nbsp;11.4.5 SK pharmteco Latest Developments &nbsp;11.5 Quotient Sciences &nbsp;11.5.1 Quotient Sciences Company Information &nbsp;11.5.2 Quotient Sciences Clinical Trial Manufacturing Service Product Offered &nbsp;11.5.3 Quotient Sciences Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Quotient Sciences Main Business Overview &nbsp;11.5.5 Quotient Sciences Latest Developments &nbsp;11.6 UPM Pharmaceuticals &nbsp;11.6.1 UPM Pharmaceuticals Company Information &nbsp;11.6.2 UPM Pharmaceuticals Clinical Trial Manufacturing Service Product Offered &nbsp;11.6.3 UPM Pharmaceuticals Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 UPM Pharmaceuticals Main Business Overview &nbsp;11.6.5 UPM Pharmaceuticals Latest Developments &nbsp;11.7 Sharp Services &nbsp;11.7.1 Sharp Services Company Information &nbsp;11.7.2 Sharp Services Clinical Trial Manufacturing Service Product Offered &nbsp;11.7.3 Sharp Services Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Sharp Services Main Business Overview &nbsp;11.7.5 Sharp Services Latest Developments &nbsp;11.8 PCI &nbsp;11.8.1 PCI Company Information &nbsp;11.8.2 PCI Clinical Trial Manufacturing Service Product Offered &nbsp;11.8.3 PCI Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 PCI Main Business Overview &nbsp;11.8.5 PCI Latest Developments &nbsp;11.9 NUVISAN &nbsp;11.9.1 NUVISAN Company Information &nbsp;11.9.2 NUVISAN Clinical Trial Manufacturing Service Product Offered &nbsp;11.9.3 NUVISAN Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 NUVISAN Main Business Overview &nbsp;11.9.5 NUVISAN Latest Developments &nbsp;11.10 Vetter-Pharma &nbsp;11.10.1 Vetter-Pharma Company Information &nbsp;11.10.2 Vetter-Pharma Clinical Trial Manufacturing Service Product Offered &nbsp;11.10.3 Vetter-Pharma Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Vetter-Pharma Main Business Overview &nbsp;11.10.5 Vetter-Pharma Latest Developments &nbsp;11.11 Lonza &nbsp;11.11.1 Lonza Company Information &nbsp;11.11.2 Lonza Clinical Trial Manufacturing Service Product Offered &nbsp;11.11.3 Lonza Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Lonza Main Business Overview &nbsp;11.11.5 Lonza Latest Developments &nbsp;11.12 MAC Research &nbsp;11.12.1 MAC Research Company Information &nbsp;11.12.2 MAC Research Clinical Trial Manufacturing Service Product Offered &nbsp;11.12.3 MAC Research Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 MAC Research Main Business Overview &nbsp;11.12.5 MAC Research Latest Developments &nbsp;11.13 Cambrex &nbsp;11.13.1 Cambrex Company Information &nbsp;11.13.2 Cambrex Clinical Trial Manufacturing Service Product Offered &nbsp;11.13.3 Cambrex Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Cambrex Main Business Overview &nbsp;11.13.5 Cambrex Latest Developments &nbsp;11.14 Nanopharm &nbsp;11.14.1 Nanopharm Company Information &nbsp;11.14.2 Nanopharm Clinical Trial Manufacturing Service Product Offered &nbsp;11.14.3 Nanopharm Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Nanopharm Main Business Overview &nbsp;11.14.5 Nanopharm Latest Developments &nbsp;11.15 Patheon &nbsp;11.15.1 Patheon Company Information &nbsp;11.15.2 Patheon Clinical Trial Manufacturing Service Product Offered &nbsp;11.15.3 Patheon Clinical Trial Manufacturing Service Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Patheon Main Business Overview &nbsp;11.15.5 Patheon Latest Developments 12 Research Findings and Conclusion

Report	Global Clinical Trial Manufacturing Service Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI17110

Buyer Information

Order Summary